Neighborhood Neuropathy Center

09/17/2025

🔑 Amputation prevention starts with proactive neuropathy care.
Peripheral neuropathy is one of the most common—and devastating—complications of diabetes, leading to ulcers, infections, and limb loss.
The NeuropaCalm Care Program equips pharmacists, chiropractors, and physical therapists with:
✔️ Infrared light therapy devices
✔️ Evidence-based clinical protocols
✔️ Patient education tools
✔️ Simple progress monitoring
Together, these tools reduce neuropathic pain, improve circulation, and help prevent amputations before they happen.
👉 Let’s give patients more than survival—we can give them independence, dignity, and mobility. Learn more: https://www.neuropacalm.com/news/amputation-prevention-in-peripheral-neuropathy-how-the-neuropacalm-care-program-is-changing-lives


(Image credit: Kampus Production | Pexels via Canva)

09/13/2025

💡 Can your clinic help more patients with peripheral neuropathy—without lowering your rates?
Over 20 million Americans suffer from peripheral neuropathy. Many can’t walk, sleep, or function without pain. Chiropractic care offers relief—but the cost of care often forces patients to walk away.
🩺 The solution? Ethical, patient-first financing.
In-house or third-party payment options remove barriers to care while increasing compliance, outcomes, and revenue.
This isn't just smart business—it's compassionate care.
👇 Read why offering financing could be the smartest, most ethical move your practice makes this year:
🔗 https://www.neuropacalm.com/news/why-chiropractors-should-offer-financing-options-for-peripheral-neuropathy-patients

09/12/2025

Peripheral neuropathy affects 20–30 million Americans, yet it’s often underdiagnosed and undertreated.

For patients, the consequences can be life-altering ... pain, loss of sensation, poor balance, even amputation.

Convenient care clinics and independent pharmacies are uniquely positioned to fill this treatment gap by offering accessible testing and therapeutic solutions.

One such option: NeuropaCalm, a red and near-infrared therapy device delivering up to 5x more power at half the cost of competing machines. Results? Improved circulation, symptom relief, and a better quality of life for patients who may have lost hope.

👉 Learn how your clinic or pharmacy can bring the NeuropaCalm Care Program to your patients: https://www.neuropacalm.com/news/peripheral-neuropathy-providing-patients-with-symptomatic-relief


(Image credit: Brothers91 | Getty Images via Canva Pro)

09/10/2025

09/04/2025

Did you know? Nearly 85% of amputations in diabetes patients begin with a small, unnoticed foot ulcer caused by peripheral neuropathy.
That’s why the NeuropaCalm Care Program exists. By improving circulation and restoring sensation with infrared light therapy, we help patients avoid ulcers, infections, and amputations—while giving them renewed hope and independence.
👉 For providers: NeuropaCalm offers clinical credibility, financial sustainability, and practice differentiation.
👉 For patients: it means pain relief, restored sensation, and freedom to keep walking into the future.
💡 Amputation is not inevitable. Together, we can change the outcome. Learn more: https://www.neuropacalm.com/news/amputation-prevention-in-peripheral-neuropathy-how-the-neuropacalm-care-program-is-changing-lives

08/22/2025

⚠️ Peripheral Neuropathy: The Overlooked Epidemic in Your Exam Room
With over 20 million Americans affected, peripheral neuropathy is quietly disabling patients—causing pain, amputations, and a steep decline in quality of life.
Yet, early detection is often missed.
Medical professionals are the first—and best—line of defense.
This article outlines what clinicians can do today to prevent long-term damage:
✅ Screen routinely
✅ Educate patients on early symptoms
✅ Manage risk factors proactively
✅ Build multidisciplinary care teams
🧠 The time to act is now. Read the full article from NeuropaCalm:
🔗 https://www.neuropacalm.com/news/the-frontline-of-hope-why-medical-professionals-must-lead-the-fight-against-peripheral-neuropathy

08/20/2025

Peripheral neuropathy is more common than most realize. Nearly 30 million diabetics may be silently struggling with pain, numbness, and mobility issues—sometimes leading to amputations.

But it doesn’t have to be this way. 🙌

With affordable, powerful treatment options like NeuropaCalm infrared therapy, patients can experience restored sensation, improved circulation, and real symptom relief.

That’s why convenient care clinics and independent pharmacies are stepping up to provide accessible testing and therapeutic solutions.

If you’re ready to improve patient outcomes in your community, discover how the NeuropaCalm Care Program can transform lives. 💙

Learn more: https://www.neuropacalm.com/news/peripheral-neuropathy-providing-patients-with-symptomatic-relief

(Image credit: Brothers91 | Getty Images via Canva Pro)

08/08/2025

🛑 How many neuropathy patients walk out your clinic doors because they can’t afford treatment?
For many, the pain is unbearable—but the price is impossible. That’s where financing changes everything.

🌿 By offering flexible payment plans, you’re not only growing your practice—you’re giving hope to patients who've been told to “just live with it.”

🔍 In this powerful article from NeuropaCalm, learn how in-house and third-party financing:
✅ Increases patient compliance
✅ Improves outcomes
✅ Strengthens your reputation
✅ Keeps your care accessible to those who need it most

👉 Read the full piece here and discover how you can make a bigger impact—starting today:
🔗 https://www.neuropacalm.com/news/why-chiropractors-should-offer-financing-options-for-peripheral-neuropathy-patients

08/06/2025

🛑 Peripheral Neuropathy is not rare. It’s underdiagnosed.
Over 20 million people in the U.S. silently suffer from this debilitating condition—often misdiagnosed or ignored until it’s too late.

🧠 The good news? Medical professionals can change that.

📋 Simple screenings during routine visits.
📣 Educating patients about early symptoms.
🧰 Managing risks before permanent damage sets in.

💬 “The Front Line of Hope” is more than a message—it’s a movement.

If you’re a clinician, caregiver, or know someone affected by neuropathy, this article is a must-read.

➡️ Read now & share to help raise awareness and save limbs—and lives.
📖 https://www.neuropacalm.com/news/the-frontline-of-hope-why-medical-professionals-must-lead-the-fight-against-peripheral-neuropathy

07/30/2025

Confronted with peripheral neuropathy, patients frequently turn to prescription medications. While these may offer temporary relief, they come with high recurring costs, potential side effects, and diminishing returns.

What’s a better approach? For many, the NeuropaCalm Care Program’s infrared light therapy offers symptomatic pain relief and better long-term healthcare management. Yet, some medical professionals fear the upfront cost of infrared light therapy devices may deter patients.

Learn more about why infrared light therapy is more affordable than you may think: https://www.neuropacalm.com/news/infrared-light-therapy-is-more-affordable-than-your-patients-may-think

(Image credit: Comstock Images | Canva Pro)

07/25/2025

Offering financing, whether in-house or through third-party lenders like Finance Your Care, breaks down the single greatest obstacle to consistent care for those suffering from peripheral neuropathy: cost. Financing allows patients to get started immediately, stay committed to their health, and experience better clinical outcomes.

From a business standpoint, this model also offers predictability in revenue and a higher acceptance rate. Patients are far more likely to say “yes” to a $200/month plan than to a $2,400 up-front cost. Chiropractors who offer flexible options become partners in their patients’ healing journeys, not just service providers. Learn more about our new third-party financing options: https://www.neuropacalm.com/news/why-chiropractors-should-offer-financing-options-for-peripheral-neuropathy-patients

(Image credit: Rido | Canva Pro)

07/23/2025

According to the National Institute of Neurological Disorders and Stroke (NINDS), neuropathy affects about 20 million people in the United States alone. Despite being so widespread, the management of neuropathy remains a challenge for many healthcare providers. Treatment often involves pain management strategies, such as pain relievers, anti-seizure medications, or antidepressants. Unfortunately, these solutions can come with significant side effects and may not address the root causes of the condition.

The limitations of conventional treatments and the growing demand for holistic, non-invasive approaches to healthcare present a strong case for adopting the NeuropaCalm Care Program into medical practices. Learn more: https://www.neuropacalm.com/news/why-medical-professionals-should-offer-the-neuropacalm-care-program-to-their-patients

(Image credit: fizkes | Getty Images via Canva Pro)